Cardiol Therapeutics (CRDL) Earnings Date & Reports
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CRDL is expected to report earnings to fall 4.32% to -8 cents per share on April 01
Q4'25
Est.
$-0.08
Q3'25
Missed
by $0.01
Q2'25
Beat
by $0.03
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.02
The last earnings report on November 18 showed earnings per share of -8 cents, missing the estimate of -7 cents. With 246.65K shares outstanding, the current market capitalization sits at 101.05M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CRDL showed earnings on November 18, 2025. You can read more about the earnings report here.